Resveratrol Effects on Inflammatory Biomarkers and Cardiometabolic Parameters.

Starting soon · Not applicable

Conditions studied: Inflammation Biomarkers, Cardiometabolic Health Indicators, Antioxidant Status, Inflammation, Antioxidant Capabilities, Inflammaging

In brief

This study aims to evaluate the effect of the supplementation of grape pomace bars enriched in resveratrol on inflammatory biomarkers and cardiometabolic parameters in community-dwelling adults

Key facts

Study ID

NCT07395921

Run by

Center for Research and Innovation Viña Concha y Toro

People needed

75

Starts

2026-06-01

Expected to finish

2026-12-01

Last updated by the study team

2026-05-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Comunnity-dwelling persons.
• Any ethnicity.
• With willingness to consume the bar daily during the intervention period.

You may not qualify if…

• Allergy/intolerance to ingredients in the bar.
• Pregnancy or breastfeeding.
• Use of antioxidant/polymeroid supplements in the last 4 weeks.
• Unstable chronic diseases (e.g., severe liver failure, advanced kidney failure, active cancer).
• Persons in treatments that strongly interfere with polyphenol metabolism (e.g., antibiotics, anti-inflammatories, corticosteroids, anti-allergy medication).
• Persons with metal prosthesis.
• Persons undergoing or waiting for metabolic bariatric surgery.
• Persons with scheduled digestive surgery within the next 8 weeks
• Persons in recent treatments for hypertension (less than 3 month).
• Participation in another clinical trial.

Where it is running

• Universidad Católica del Maule — Talca, Maule Region, Chile

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.